Market Cap (In USD)
22.28 Million
Revenue (In USD)
17.06 Thousand
Net Income (In USD)
-8.37 Million
Avg. Volume
1.28 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.19-3.56
- PE
- -1.38
- EPS
- -0.31
- Beta Value
- 4.679
- ISIN
- US14159C1036
- CUSIP
- 14159C103
- CIK
- 1870144
- Shares
- 52145416.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Meeshanthini V. Dogan Ph.D.
- Employee Count
- -
- Website
- https://cardiodiagnosticsinc.com
- Ipo Date
- 2022-01-14
- Details
- Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
More Stocks
-
0K3W
-
ITGR
-
9991Baozun Inc.
9991
-
HGBLHeritage Global Inc.
HGBL
-
GCAAF
-
RGT
-
TTKPRESTIGTTK Prestige Limited
TTKPRESTIG
-
BRSGF